SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+0.81%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$357M
AUM Growth
+$357M
(-3.9%)
Cap. Flow
-$9.3M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
48.13%
Holding
117
New
28
Increased
20
Reduced
20
Closed
27
Top Buys
| 1 |
Eli Lilly
LLY
|
$15.8M |
| 2 |
Amgen
AMGN
|
$12.9M |
| 3 |
GSK
GSK
|
$6.39M |
| 4 |
SHPG
Shire pic
SHPG
|
$6.19M |
| 5 |
Merck
MRK
|
$5.76M |
Top Sells
| 1 |
Pfizer
PFE
|
$35.2M |
| 2 |
Biogen
BIIB
|
$16.5M |
| 3 |
Ormat Technologies
ORA
|
$13.3M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$6.28M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$4.39M |
Sector Composition
| 1 | Healthcare | 83.1% |
| 2 | Technology | 4.73% |
| 3 | Communication Services | 1.85% |
| 4 | Consumer Discretionary | 1.25% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $30.1M | 7.83% | 600,200 -125,000 | -17% | -$6.28M |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $22M | 5.7% | 95,000 -5,000 | -5% | -$1.16M |
|
|
SHPG
3
DELISTED
Shire pic
SHPG
| $21.6M | 5.61% | 264,539 +75,863 | +40% | +$6.19M |
|
4
Gilead Sciences
GILD
$140B
| $16.1M | 4.17% | 192,700 +20,000 | +12% | +$1.67M |
|
|
5
Eli Lilly
LLY
$657B
| $15.8M | 4.09% | +200,000 | New | +$15.8M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $15.3M | 3.97% | 155,000 +55,000 | +55% | +$5.42M |
|
|
7
Pfizer
PFE
$141B
| $15M | 3.9% | 426,612 -1,000,000 | -70% | -$35.2M |
|
|
8
Amgen
AMGN
$155B
| $12.9M | 3.36% | +85,000 | New | +$12.9M |
|
|
9
Biogen
BIIB
$19.4B
| $12.2M | 3.17% | 50,500 -68,350 | -58% | -$16.5M |
|
10
Viatris
VTRS
$12.3B
| $10.8M | 2.81% | 250,000 -37,827 | -13% | -$1.64M |
|
11
Ituran Location and Control
ITRN
$671M
| $10.4M | 2.71% | 460,452 -11,132 | -2% | -$253K |
|
|
12
GSK
GSK
$79.9B
| $6.39M | 1.66% | +398,287 | New | +$6.39M |
|
|
13
Merck
MRK
$210B
| $5.76M | 1.5% | +100,000 | New | +$5.76M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $5.49M | 1.42% | 1,005,000 +705,000 | +235% | +$3.85M |
|
|
CBIO
15
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $5.22M | 1.36% | 718,080 +380,169 | +113% | +$2.76M |
|
16
Ultragenyx Pharmaceutical
RARE
$2.89B
| $5.14M | 1.33% | +105,000 | New | +$5.14M |
|
17
Vertex Pharmaceuticals
VRTX
$100B
| $4.96M | 1.29% | +57,600 | New | +$4.96M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.94M | 1.28% | 42,323 +2,323 | +6% | +$271K |
|
|
AKAO
19
DELISTED
Achaogen, Inc.
AKAO
| $4.77M | 1.24% | +1,257,366 | New | +$4.77M |
|
20
Corvus Pharmaceuticals
CRVS
$428M
| $4.58M | 1.19% | 325,053 +214,132 | +193% | +$3.02M |
|
21
Advance Auto Parts
AAP
$3.66B
| $4.47M | 1.16% | 27,662 +7,526 | +37% | +$1.22M |
|
|
NDRM
22
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $4.2M | 1.09% | 258,513 +92,154 | +55% | +$1.5M |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $4.09M | 1.06% | 270,000 | – | – |
|
|
CLCD
24
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
| $4.09M | 1.06% | 500,137 +221,800 | +80% | +$1.81M |
|
|
KERX
25
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $3.73M | 0.97% | +562,900 | New | +$3.73M |
|